Paul Knight
Stock Analyst at Keybanc
(2.38)
# 2,586
Out of 4,981 analysts
137
Total ratings
46.9%
Success rate
-1.8%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFCR Lifecore Biomedical | Initiates: Sector Weight | n/a | $7.48 | - | 1 | Sep 4, 2025 | |
| ATR AptarGroup | Initiates: Overweight | $220 | $135.23 | +62.69% | 1 | Sep 4, 2025 | |
| CYRX Cryoport | Upgrades: Overweight | $15 | $8.64 | +73.61% | 9 | Aug 6, 2025 | |
| XGN Exagen | Upgrades: Overweight | $17 | $9.74 | +74.54% | 6 | Jul 30, 2025 | |
| EHC Encompass Health | Maintains: Overweight | $122 → $135 | $126.05 | +7.10% | 1 | May 27, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $0.44 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $51.26 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $295.39 | +55.73% | 5 | Mar 31, 2025 | |
| LAB Standard BioTools | Downgrades: Sector Weight | n/a | $1.29 | - | 2 | Feb 27, 2025 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $470 → $325 | $253.50 | +28.21% | 11 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $8 | $3.03 | +164.46% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $145 | $82.87 | +74.97% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $159.87 | +162.72% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $118.50 | +94.09% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $25.51 | +29.36% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $21.42 | +68.07% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $190.05 | +63.11% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $113.54 | +93.76% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $479.46 | - | 6 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $37 | $26.42 | +40.05% | 5 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $2.65 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $4.45 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $123.24 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $29.66 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $12.31 | +224.94% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $152.89 | +96.22% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $187.22 | +33.53% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $130.31 | +238.42% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $130.38 | +81.01% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $66.68 | +48.47% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $12.22 | +350.08% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $30.88 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $61.57 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $95.12 | - | 5 | Oct 23, 2017 |
Lifecore Biomedical
Sep 4, 2025
Initiates: Sector Weight
Price Target: n/a
Current: $7.48
Upside: -
AptarGroup
Sep 4, 2025
Initiates: Overweight
Price Target: $220
Current: $135.23
Upside: +62.69%
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $8.64
Upside: +73.61%
Exagen
Jul 30, 2025
Upgrades: Overweight
Price Target: $17
Current: $9.74
Upside: +74.54%
Encompass Health
May 27, 2025
Maintains: Overweight
Price Target: $122 → $135
Current: $126.05
Upside: +7.10%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.44
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $51.26
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $295.39
Upside: +55.73%
Standard BioTools
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $1.29
Upside: -
West Pharmaceutical Services
Feb 14, 2025
Maintains: Overweight
Price Target: $470 → $325
Current: $253.50
Upside: +28.21%
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $3.03
Upside: +164.46%
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $82.87
Upside: +74.97%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $159.87
Upside: +162.72%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $118.50
Upside: +94.09%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $25.51
Upside: +29.36%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $21.42
Upside: +68.07%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $190.05
Upside: +63.11%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $113.54
Upside: +93.76%
Oct 26, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $479.46
Upside: -
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $26.42
Upside: +40.05%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $2.65
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $4.45
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $123.24
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $29.66
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $12.31
Upside: +224.94%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $152.89
Upside: +96.22%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $187.22
Upside: +33.53%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $130.31
Upside: +238.42%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $130.38
Upside: +81.01%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $66.68
Upside: +48.47%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $12.22
Upside: +350.08%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $30.88
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $61.57
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $95.12
Upside: -